What is Sermorelin?
Sermorelin is a 29-amino-acid amide corresponding to the active N-terminal fragment of native GHRH. It retains full GHRH-receptor binding activity in a more economical, easier-to-manufacture sequence than the full 44-residue parent peptide.
Sermorelin is widely used as a research benchmark for pulsatile somatotropic-axis stimulation and is frequently studied alongside Tesamorelin and CJC-1295 as part of GHRH-class investigations.
How it's studied — mechanism
Sermorelin binds the GHRH receptor on pituitary somatotrophs, evoking a physiologic pulse of endogenous growth hormone — preserving the body's negative-feedback architecture, unlike exogenous GH administration. Downstream effects mirror native GHRH activity.
Amino acid sequence
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂Published research
The following primary sources are provided to support qualified-researcher review. Inclusion is for reference only and does not constitute medical advice or therapeutic claim.